nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—PTGS2—amyotrophic lateral sclerosis	0.411	1	CbGaD
Celecoxib—Angina unstable—Riluzole—amyotrophic lateral sclerosis	0.00948	0.0312	CcSEcCtD
Celecoxib—Skin nodule—Riluzole—amyotrophic lateral sclerosis	0.00863	0.0284	CcSEcCtD
Celecoxib—Skin mass—Riluzole—amyotrophic lateral sclerosis	0.00773	0.0255	CcSEcCtD
Celecoxib—Haematocrit decreased—Riluzole—amyotrophic lateral sclerosis	0.00643	0.0212	CcSEcCtD
Celecoxib—Rectal tenesmus—Riluzole—amyotrophic lateral sclerosis	0.00643	0.0212	CcSEcCtD
Celecoxib—Stiffness—Riluzole—amyotrophic lateral sclerosis	0.0063	0.0208	CcSEcCtD
Celecoxib—PDPK1—embryo—amyotrophic lateral sclerosis	0.00571	0.0628	CbGeAlD
Celecoxib—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.00511	0.0168	CcSEcCtD
Celecoxib—MAPK14—hindbrain—amyotrophic lateral sclerosis	0.00488	0.0537	CbGeAlD
Celecoxib—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00438	0.0144	CcSEcCtD
Celecoxib—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00433	0.0143	CcSEcCtD
Celecoxib—Urine analysis abnormal—Riluzole—amyotrophic lateral sclerosis	0.00407	0.0134	CcSEcCtD
Celecoxib—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.00407	0.0134	CcSEcCtD
Celecoxib—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.00403	0.0133	CcSEcCtD
Celecoxib—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.00369	0.0122	CcSEcCtD
Celecoxib—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00366	0.012	CcSEcCtD
Celecoxib—PDPK1—medulla oblongata—amyotrophic lateral sclerosis	0.00365	0.0401	CbGeAlD
Celecoxib—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00351	0.0116	CcSEcCtD
Celecoxib—Haemoglobin decreased—Riluzole—amyotrophic lateral sclerosis	0.00348	0.0115	CcSEcCtD
Celecoxib—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.00348	0.0115	CcSEcCtD
Celecoxib—Ileus—Riluzole—amyotrophic lateral sclerosis	0.00338	0.0111	CcSEcCtD
Celecoxib—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00332	0.0109	CcSEcCtD
Celecoxib—PDPK1—spinal cord—amyotrophic lateral sclerosis	0.00325	0.0358	CbGeAlD
Celecoxib—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00318	0.0105	CcSEcCtD
Celecoxib—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00313	0.0103	CcSEcCtD
Celecoxib—PTGS2—hindlimb—amyotrophic lateral sclerosis	0.00308	0.0339	CbGeAlD
Celecoxib—CA4—nerve—amyotrophic lateral sclerosis	0.00306	0.0337	CbGeAlD
Celecoxib—MAPK14—embryo—amyotrophic lateral sclerosis	0.00305	0.0336	CbGeAlD
Celecoxib—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00298	0.00982	CcSEcCtD
Celecoxib—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00296	0.00974	CcSEcCtD
Celecoxib—MAPK14—brainstem—amyotrophic lateral sclerosis	0.0028	0.0308	CbGeAlD
Celecoxib—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00905	CcSEcCtD
Celecoxib—PDPK1—nervous system—amyotrophic lateral sclerosis	0.00274	0.0301	CbGeAlD
Celecoxib—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00267	0.0088	CcSEcCtD
Celecoxib—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00874	CcSEcCtD
Celecoxib—PTGS2—appendage—amyotrophic lateral sclerosis	0.00264	0.0291	CbGeAlD
Celecoxib—PDPK1—central nervous system—amyotrophic lateral sclerosis	0.00264	0.029	CbGeAlD
Celecoxib—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00263	0.00868	CcSEcCtD
Celecoxib—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00263	0.00868	CcSEcCtD
Celecoxib—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00258	0.00851	CcSEcCtD
Celecoxib—PDPK1—cerebellum—amyotrophic lateral sclerosis	0.00258	0.0284	CbGeAlD
Celecoxib—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00834	CcSEcCtD
Celecoxib—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00834	CcSEcCtD
Celecoxib—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00252	0.00829	CcSEcCtD
Celecoxib—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00789	CcSEcCtD
Celecoxib—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00789	CcSEcCtD
Celecoxib—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00785	CcSEcCtD
Celecoxib—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00237	0.0078	CcSEcCtD
Celecoxib—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00771	CcSEcCtD
Celecoxib—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00762	CcSEcCtD
Celecoxib—CA4—hindbrain—amyotrophic lateral sclerosis	0.00229	0.0252	CbGeAlD
Celecoxib—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00229	0.00753	CcSEcCtD
Celecoxib—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00749	CcSEcCtD
Celecoxib—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00741	CcSEcCtD
Celecoxib—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00725	CcSEcCtD
Celecoxib—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00714	CcSEcCtD
Celecoxib—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00714	CcSEcCtD
Celecoxib—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00692	CcSEcCtD
Celecoxib—PDPK1—brain—amyotrophic lateral sclerosis	0.0021	0.023	CbGeAlD
Celecoxib—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00685	CcSEcCtD
Celecoxib—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00204	0.00671	CcSEcCtD
Celecoxib—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.002	0.00659	CcSEcCtD
Celecoxib—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.002	0.00659	CcSEcCtD
Celecoxib—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00656	CcSEcCtD
Celecoxib—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00652	CcSEcCtD
Celecoxib—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00194	0.0064	CcSEcCtD
Celecoxib—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00632	CcSEcCtD
Celecoxib—CA2—hindbrain—amyotrophic lateral sclerosis	0.0019	0.0209	CbGeAlD
Celecoxib—CA14—medulla oblongata—amyotrophic lateral sclerosis	0.0019	0.0209	CbGeAlD
Celecoxib—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00185	0.0061	CcSEcCtD
Celecoxib—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00607	CcSEcCtD
Celecoxib—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00592	CcSEcCtD
Celecoxib—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00587	CcSEcCtD
Celecoxib—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00575	CcSEcCtD
Celecoxib—MAPK14—spinal cord—amyotrophic lateral sclerosis	0.00174	0.0191	CbGeAlD
Celecoxib—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00573	CcSEcCtD
Celecoxib—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00573	CcSEcCtD
Celecoxib—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00564	CcSEcCtD
Celecoxib—CA14—spinal cord—amyotrophic lateral sclerosis	0.00169	0.0186	CbGeAlD
Celecoxib—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00553	CcSEcCtD
Celecoxib—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00539	CcSEcCtD
Celecoxib—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00529	CcSEcCtD
Celecoxib—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00521	CcSEcCtD
Celecoxib—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00518	CcSEcCtD
Celecoxib—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00516	CcSEcCtD
Celecoxib—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00507	CcSEcCtD
Celecoxib—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00505	CcSEcCtD
Celecoxib—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00495	CcSEcCtD
Celecoxib—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00485	CcSEcCtD
Celecoxib—MAPK14—nervous system—amyotrophic lateral sclerosis	0.00147	0.0161	CbGeAlD
Celecoxib—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00482	CcSEcCtD
Celecoxib—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00476	CcSEcCtD
Celecoxib—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00143	0.0047	CcSEcCtD
Celecoxib—Etoricoxib—PTGS2—amyotrophic lateral sclerosis	0.00142	1	CrCbGaD
Celecoxib—CA9—cerebellum—amyotrophic lateral sclerosis	0.00141	0.0156	CbGeAlD
Celecoxib—MAPK14—central nervous system—amyotrophic lateral sclerosis	0.00141	0.0155	CbGeAlD
Celecoxib—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00463	CcSEcCtD
Celecoxib—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00457	CcSEcCtD
Celecoxib—MAPK14—cerebellum—amyotrophic lateral sclerosis	0.00138	0.0152	CbGeAlD
Celecoxib—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00452	CcSEcCtD
Celecoxib—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00451	CcSEcCtD
Celecoxib—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00444	CcSEcCtD
Celecoxib—CA14—cerebellum—amyotrophic lateral sclerosis	0.00134	0.0148	CbGeAlD
Celecoxib—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00441	CcSEcCtD
Celecoxib—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00441	CcSEcCtD
Celecoxib—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00435	CcSEcCtD
Celecoxib—CA4—brainstem—amyotrophic lateral sclerosis	0.00131	0.0145	CbGeAlD
Celecoxib—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00433	CcSEcCtD
Celecoxib—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00433	CcSEcCtD
Celecoxib—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0043	CcSEcCtD
Celecoxib—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0043	CcSEcCtD
Celecoxib—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00429	CcSEcCtD
Celecoxib—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00421	CcSEcCtD
Celecoxib—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00418	CcSEcCtD
Celecoxib—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00416	CcSEcCtD
Celecoxib—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00414	CcSEcCtD
Celecoxib—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00412	CcSEcCtD
Celecoxib—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00398	CcSEcCtD
Celecoxib—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00121	0.0133	CbGeAlD
Celecoxib—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00397	CcSEcCtD
Celecoxib—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00396	CcSEcCtD
Celecoxib—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00396	CcSEcCtD
Celecoxib—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00394	CcSEcCtD
Celecoxib—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00394	CcSEcCtD
Celecoxib—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00393	CcSEcCtD
Celecoxib—CA2—embryo—amyotrophic lateral sclerosis	0.00119	0.0131	CbGeAlD
Celecoxib—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00391	CcSEcCtD
Celecoxib—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00119	0.0039	CcSEcCtD
Celecoxib—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00389	CcSEcCtD
Celecoxib—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00388	CcSEcCtD
Celecoxib—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00375	CcSEcCtD
Celecoxib—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00112	0.0037	CcSEcCtD
Celecoxib—MAPK14—brain—amyotrophic lateral sclerosis	0.00112	0.0123	CbGeAlD
Celecoxib—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00368	CcSEcCtD
Celecoxib—CA12—nervous system—amyotrophic lateral sclerosis	0.00111	0.0122	CbGeAlD
Celecoxib—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00109	0.0036	CcSEcCtD
Celecoxib—CA14—brain—amyotrophic lateral sclerosis	0.00109	0.012	CbGeAlD
Celecoxib—CA2—brainstem—amyotrophic lateral sclerosis	0.00109	0.012	CbGeAlD
Celecoxib—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00358	CcSEcCtD
Celecoxib—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00357	CcSEcCtD
Celecoxib—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00354	CcSEcCtD
Celecoxib—CA12—central nervous system—amyotrophic lateral sclerosis	0.00107	0.0118	CbGeAlD
Celecoxib—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00106	0.0035	CcSEcCtD
Celecoxib—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00347	CcSEcCtD
Celecoxib—ORM1—spinal cord—amyotrophic lateral sclerosis	0.00105	0.0115	CbGeAlD
Celecoxib—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00103	0.0034	CcSEcCtD
Celecoxib—Tension—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00339	CcSEcCtD
Celecoxib—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00338	CcSEcCtD
Celecoxib—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00335	CcSEcCtD
Celecoxib—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00334	CcSEcCtD
Celecoxib—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00332	CcSEcCtD
Celecoxib—CA5B—nervous system—amyotrophic lateral sclerosis	0.000998	0.011	CbGeAlD
Celecoxib—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000968	0.00319	CcSEcCtD
Celecoxib—CA5B—central nervous system—amyotrophic lateral sclerosis	0.000961	0.0106	CbGeAlD
Celecoxib—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000957	0.00315	CcSEcCtD
Celecoxib—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000941	0.0031	CcSEcCtD
Celecoxib—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000939	0.00309	CcSEcCtD
Celecoxib—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000937	0.00309	CcSEcCtD
Celecoxib—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000926	0.00305	CcSEcCtD
Celecoxib—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00092	0.00303	CcSEcCtD
Celecoxib—CA4—medulla oblongata—amyotrophic lateral sclerosis	0.000917	0.0101	CbGeAlD
Celecoxib—Cough—Riluzole—amyotrophic lateral sclerosis	0.000914	0.00301	CcSEcCtD
Celecoxib—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000904	0.00298	CcSEcCtD
Celecoxib—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000892	0.00294	CcSEcCtD
Celecoxib—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000892	0.00294	CcSEcCtD
Celecoxib—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000892	0.00294	CcSEcCtD
Celecoxib—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000889	0.00293	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000885	0.00292	CcSEcCtD
Celecoxib—ORM1—nervous system—amyotrophic lateral sclerosis	0.000883	0.00971	CbGeAlD
Celecoxib—PTGS2—embryo—amyotrophic lateral sclerosis	0.000878	0.00966	CbGeAlD
Celecoxib—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000872	0.00287	CcSEcCtD
Celecoxib—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000862	0.00284	CcSEcCtD
Celecoxib—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000855	0.00282	CcSEcCtD
Celecoxib—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000855	0.00282	CcSEcCtD
Celecoxib—CA12—brain—amyotrophic lateral sclerosis	0.00085	0.00935	CbGeAlD
Celecoxib—ORM1—central nervous system—amyotrophic lateral sclerosis	0.00085	0.00934	CbGeAlD
Celecoxib—Infection—Riluzole—amyotrophic lateral sclerosis	0.000849	0.0028	CcSEcCtD
Celecoxib—Shock—Riluzole—amyotrophic lateral sclerosis	0.000841	0.00277	CcSEcCtD
Celecoxib—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000838	0.00276	CcSEcCtD
Celecoxib—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000837	0.00276	CcSEcCtD
Celecoxib—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000834	0.00275	CcSEcCtD
Celecoxib—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00083	0.00273	CcSEcCtD
Celecoxib—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000826	0.00272	CcSEcCtD
Celecoxib—CA4—spinal cord—amyotrophic lateral sclerosis	0.000817	0.00899	CbGeAlD
Celecoxib—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000815	0.00268	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000779	0.00257	CcSEcCtD
Celecoxib—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000773	0.00255	CcSEcCtD
Celecoxib—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000768	0.00253	CcSEcCtD
Celecoxib—CA5B—brain—amyotrophic lateral sclerosis	0.000763	0.00839	CbGeAlD
Celecoxib—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000762	0.00251	CcSEcCtD
Celecoxib—CA2—medulla oblongata—amyotrophic lateral sclerosis	0.00076	0.00836	CbGeAlD
Celecoxib—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00076	0.0025	CcSEcCtD
Celecoxib—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000752	0.00248	CcSEcCtD
Celecoxib—ABCC4—nervous system—amyotrophic lateral sclerosis	0.000749	0.00824	CbGeAlD
Celecoxib—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000743	0.00245	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000738	0.00243	CcSEcCtD
Celecoxib—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000737	0.00243	CcSEcCtD
Celecoxib—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000731	0.00241	CcSEcCtD
Celecoxib—ABCC4—central nervous system—amyotrophic lateral sclerosis	0.000721	0.00793	CbGeAlD
Celecoxib—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000704	0.00232	CcSEcCtD
Celecoxib—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000699	0.0023	CcSEcCtD
Celecoxib—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000692	0.00761	CbGeAlD
Celecoxib—CA4—nervous system—amyotrophic lateral sclerosis	0.000689	0.00757	CbGeAlD
Celecoxib—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000679	0.00224	CcSEcCtD
Celecoxib—CA2—spinal cord—amyotrophic lateral sclerosis	0.000678	0.00745	CbGeAlD
Celecoxib—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000676	0.00223	CcSEcCtD
Celecoxib—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000676	0.00223	CcSEcCtD
Celecoxib—CA4—central nervous system—amyotrophic lateral sclerosis	0.000663	0.00729	CbGeAlD
Celecoxib—CA4—cerebellum—amyotrophic lateral sclerosis	0.000648	0.00713	CbGeAlD
Celecoxib—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00063	0.00207	CcSEcCtD
Celecoxib—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000613	0.00202	CcSEcCtD
Celecoxib—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000605	0.00199	CcSEcCtD
Celecoxib—ALB—brain—amyotrophic lateral sclerosis	0.000592	0.00651	CbGeAlD
Celecoxib—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000585	0.00193	CcSEcCtD
Celecoxib—ABCC4—brain—amyotrophic lateral sclerosis	0.000573	0.0063	CbGeAlD
Celecoxib—CA2—nervous system—amyotrophic lateral sclerosis	0.000571	0.00628	CbGeAlD
Celecoxib—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000565	0.00186	CcSEcCtD
Celecoxib—PTGS2—medulla oblongata—amyotrophic lateral sclerosis	0.000561	0.00617	CbGeAlD
Celecoxib—CA2—central nervous system—amyotrophic lateral sclerosis	0.00055	0.00605	CbGeAlD
Celecoxib—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000543	0.00179	CcSEcCtD
Celecoxib—Rash—Riluzole—amyotrophic lateral sclerosis	0.000539	0.00178	CcSEcCtD
Celecoxib—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000538	0.00177	CcSEcCtD
Celecoxib—CA2—cerebellum—amyotrophic lateral sclerosis	0.000537	0.00591	CbGeAlD
Celecoxib—Headache—Riluzole—amyotrophic lateral sclerosis	0.000535	0.00176	CcSEcCtD
Celecoxib—CA4—brain—amyotrophic lateral sclerosis	0.000526	0.00579	CbGeAlD
Celecoxib—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000508	0.00167	CcSEcCtD
Celecoxib—PTGS2—spinal cord—amyotrophic lateral sclerosis	0.0005	0.0055	CbGeAlD
Celecoxib—CA2—brain—amyotrophic lateral sclerosis	0.000437	0.0048	CbGeAlD
Celecoxib—PTGS2—nervous system—amyotrophic lateral sclerosis	0.000422	0.00464	CbGeAlD
Celecoxib—PTGS2—central nervous system—amyotrophic lateral sclerosis	0.000406	0.00446	CbGeAlD
Celecoxib—PTGS2—cerebellum—amyotrophic lateral sclerosis	0.000397	0.00436	CbGeAlD
Celecoxib—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000368	0.00405	CbGeAlD
Celecoxib—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000363	0.00399	CbGeAlD
Celecoxib—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000355	0.0039	CbGeAlD
Celecoxib—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000349	0.00384	CbGeAlD
Celecoxib—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000341	0.00375	CbGeAlD
Celecoxib—PTGS2—brain—amyotrophic lateral sclerosis	0.000322	0.00354	CbGeAlD
Celecoxib—CYP2D6—brain—amyotrophic lateral sclerosis	0.000277	0.00305	CbGeAlD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	9.18e-05	0.000476	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	9.06e-05	0.00047	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—C3—amyotrophic lateral sclerosis	8.99e-05	0.000466	CbGpPWpGaD
Celecoxib—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	8.95e-05	0.000464	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	8.92e-05	0.000463	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by VEGF—VEGFA—amyotrophic lateral sclerosis	8.88e-05	0.000461	CbGpPWpGaD
Celecoxib—MAPK14—Glucocorticoid receptor regulatory network—TP53—amyotrophic lateral sclerosis	8.8e-05	0.000456	CbGpPWpGaD
Celecoxib—MAPK14—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	8.74e-05	0.000454	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—SQSTM1—amyotrophic lateral sclerosis	8.58e-05	0.000445	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	8.52e-05	0.000442	CbGpPWpGaD
Celecoxib—CA9—Metabolism—CHAT—amyotrophic lateral sclerosis	8.32e-05	0.000432	CbGpPWpGaD
Celecoxib—CA14—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.23e-05	0.000427	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	8.17e-05	0.000424	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—RARA—amyotrophic lateral sclerosis	8.17e-05	0.000424	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	8.09e-05	0.00042	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	8.08e-05	0.000419	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	8.06e-05	0.000418	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—ATF1—amyotrophic lateral sclerosis	8.05e-05	0.000418	CbGpPWpGaD
Celecoxib—CA6—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.02e-05	0.000416	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.02e-05	0.000416	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—IGF1—amyotrophic lateral sclerosis	8e-05	0.000415	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—SOD1—amyotrophic lateral sclerosis	7.79e-05	0.000404	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—CASP3—amyotrophic lateral sclerosis	7.73e-05	0.000401	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—TPK1—amyotrophic lateral sclerosis	7.72e-05	0.000401	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—VAPB—amyotrophic lateral sclerosis	7.72e-05	0.000401	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	7.69e-05	0.000399	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CASP9—amyotrophic lateral sclerosis	7.67e-05	0.000398	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	7.57e-05	0.000393	CbGpPWpGaD
Celecoxib—CA14—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.56e-05	0.000392	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	7.52e-05	0.00039	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	7.51e-05	0.00039	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.49e-05	0.000388	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.37e-05	0.000382	CbGpPWpGaD
Celecoxib—CA6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.37e-05	0.000382	CbGpPWpGaD
Celecoxib—PTGS2—Disease—VTA1—amyotrophic lateral sclerosis	7.37e-05	0.000382	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	7.29e-05	0.000378	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	7.22e-05	0.000375	CbGpPWpGaD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—TP53—amyotrophic lateral sclerosis	7.22e-05	0.000374	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	7.2e-05	0.000373	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—ATF1—amyotrophic lateral sclerosis	7.18e-05	0.000373	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CASP9—amyotrophic lateral sclerosis	7.08e-05	0.000367	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—VAPA—amyotrophic lateral sclerosis	7.06e-05	0.000366	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	6.98e-05	0.000362	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—DCTN1—amyotrophic lateral sclerosis	6.98e-05	0.000362	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	6.98e-05	0.000362	CbGpPWpGaD
Celecoxib—CA12—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.94e-05	0.00036	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.88e-05	0.000357	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CASP9—amyotrophic lateral sclerosis	6.84e-05	0.000355	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	6.84e-05	0.000355	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—SOD1—amyotrophic lateral sclerosis	6.82e-05	0.000354	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.75e-05	0.00035	CbGpPWpGaD
Celecoxib—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.73e-05	0.000349	CbGpPWpGaD
Celecoxib—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.67e-05	0.000346	CbGpPWpGaD
Celecoxib—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.64e-05	0.000344	CbGpPWpGaD
Celecoxib—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.58e-05	0.000341	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.57e-05	0.000341	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.57e-05	0.000341	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—ERBB4—amyotrophic lateral sclerosis	6.56e-05	0.00034	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	6.55e-05	0.00034	CbGpPWpGaD
Celecoxib—MAPK14—Oxidative Stress Induced Senescence—TP53—amyotrophic lateral sclerosis	6.53e-05	0.000339	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	6.51e-05	0.000338	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.38e-05	0.000331	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	6.29e-05	0.000326	CbGpPWpGaD
Celecoxib—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	6.25e-05	0.000324	CbGpPWpGaD
Celecoxib—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	6.25e-05	0.000324	CbGpPWpGaD
Celecoxib—CA14—Metabolism—APOE—amyotrophic lateral sclerosis	6.22e-05	0.000323	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	6.19e-05	0.000321	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—FIG4—amyotrophic lateral sclerosis	6.17e-05	0.00032	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CD40LG—amyotrophic lateral sclerosis	6.17e-05	0.00032	CbGpPWpGaD
Celecoxib—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	6.14e-05	0.000318	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	6.13e-05	0.000318	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	6.11e-05	0.000317	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—APOE—amyotrophic lateral sclerosis	6.07e-05	0.000315	CbGpPWpGaD
Celecoxib—CA6—Metabolism—APOE—amyotrophic lateral sclerosis	6.07e-05	0.000315	CbGpPWpGaD
Celecoxib—PDPK1—Disease—ERBB4—amyotrophic lateral sclerosis	6.06e-05	0.000314	CbGpPWpGaD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	6.02e-05	0.000312	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—TP53—amyotrophic lateral sclerosis	6.01e-05	0.000312	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.97e-05	0.00031	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	5.92e-05	0.000307	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	5.85e-05	0.000304	CbGpPWpGaD
Celecoxib—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	5.85e-05	0.000303	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.83e-05	0.000302	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	5.79e-05	0.0003	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	5.72e-05	0.000297	CbGpPWpGaD
Celecoxib—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	5.71e-05	0.000296	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—APOE—amyotrophic lateral sclerosis	5.66e-05	0.000294	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CHMP2B—amyotrophic lateral sclerosis	5.59e-05	0.00029	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	5.58e-05	0.00029	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.55e-05	0.000288	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5.54e-05	0.000287	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5.54e-05	0.000287	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	5.54e-05	0.000287	CbGpPWpGaD
Celecoxib—CA4—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.53e-05	0.000287	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—C3—amyotrophic lateral sclerosis	5.45e-05	0.000283	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	5.41e-05	0.000281	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.31e-05	0.000276	CbGpPWpGaD
Celecoxib—CA2—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.3e-05	0.000275	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	5.27e-05	0.000273	CbGpPWpGaD
Celecoxib—CA12—Metabolism—APOE—amyotrophic lateral sclerosis	5.25e-05	0.000272	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—VEGFA—amyotrophic lateral sclerosis	5.22e-05	0.000271	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	5.21e-05	0.00027	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.2e-05	0.00027	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	5.16e-05	0.000268	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	5.16e-05	0.000268	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	5.11e-05	0.000265	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	5.11e-05	0.000265	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.08e-05	0.000264	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	5.05e-05	0.000262	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	5.05e-05	0.000262	CbGpPWpGaD
Celecoxib—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	4.99e-05	0.000259	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.96e-05	0.000257	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TP53—amyotrophic lateral sclerosis	4.96e-05	0.000257	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.94e-05	0.000256	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VCP—amyotrophic lateral sclerosis	4.94e-05	0.000256	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.87e-05	0.000253	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—C3—amyotrophic lateral sclerosis	4.86e-05	0.000252	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	4.78e-05	0.000248	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.77e-05	0.000247	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—IGF1—amyotrophic lateral sclerosis	4.75e-05	0.000246	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	4.72e-05	0.000245	CbGpPWpGaD
Celecoxib—PDPK1—Disease—APOE—amyotrophic lateral sclerosis	4.69e-05	0.000243	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	4.68e-05	0.000243	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	4.57e-05	0.000237	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—TP53—amyotrophic lateral sclerosis	4.57e-05	0.000237	CbGpPWpGaD
Celecoxib—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	4.52e-05	0.000234	CbGpPWpGaD
Celecoxib—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	4.5e-05	0.000234	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	4.47e-05	0.000232	CbGpPWpGaD
Celecoxib—CA9—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.47e-05	0.000232	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—SQSTM1—amyotrophic lateral sclerosis	4.46e-05	0.000231	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	4.46e-05	0.000231	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.4e-05	0.000228	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.39e-05	0.000228	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.35e-05	0.000226	CbGpPWpGaD
Celecoxib—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.34e-05	0.000225	CbGpPWpGaD
Celecoxib—CA14—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.26e-05	0.000221	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	4.24e-05	0.00022	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.24e-05	0.00022	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	4.23e-05	0.000219	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	4.2e-05	0.000218	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	4.2e-05	0.000218	CbGpPWpGaD
Celecoxib—CA4—Metabolism—APOE—amyotrophic lateral sclerosis	4.18e-05	0.000217	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—ATF1—amyotrophic lateral sclerosis	4.18e-05	0.000217	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	4.17e-05	0.000216	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—IGF1—amyotrophic lateral sclerosis	4.16e-05	0.000216	CbGpPWpGaD
Celecoxib—CA6—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.16e-05	0.000216	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.16e-05	0.000216	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	4.12e-05	0.000214	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.11e-05	0.000213	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	4.09e-05	0.000212	CbGpPWpGaD
Celecoxib—CA2—Metabolism—APOE—amyotrophic lateral sclerosis	4.01e-05	0.000208	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.99e-05	0.000207	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CASP9—amyotrophic lateral sclerosis	3.98e-05	0.000207	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TP53—amyotrophic lateral sclerosis	3.95e-05	0.000205	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	3.9e-05	0.000203	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.88e-05	0.000201	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	3.78e-05	0.000196	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	3.73e-05	0.000193	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	3.7e-05	0.000192	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.59e-05	0.000186	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.56e-05	0.000184	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.53e-05	0.000183	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	3.52e-05	0.000183	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	3.45e-05	0.000179	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	3.42e-05	0.000178	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—ERBB4—amyotrophic lateral sclerosis	3.41e-05	0.000177	CbGpPWpGaD
Celecoxib—CA9—Metabolism—APOE—amyotrophic lateral sclerosis	3.38e-05	0.000175	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	3.37e-05	0.000175	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	3.37e-05	0.000175	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.28e-05	0.00017	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	3.23e-05	0.000168	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PTGS2—amyotrophic lateral sclerosis	3.21e-05	0.000167	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	3.21e-05	0.000166	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD40LG—amyotrophic lateral sclerosis	3.21e-05	0.000166	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	3.16e-05	0.000164	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	3.16e-05	0.000164	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—VEGFA—amyotrophic lateral sclerosis	3.1e-05	0.000161	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	3.08e-05	0.00016	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MMP9—amyotrophic lateral sclerosis	3.08e-05	0.00016	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.93e-05	0.000152	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.88e-05	0.00015	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.88e-05	0.000149	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.87e-05	0.000149	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.87e-05	0.000149	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.86e-05	0.000148	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—C3—amyotrophic lateral sclerosis	2.83e-05	0.000147	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	2.83e-05	0.000147	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	2.8e-05	0.000145	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.77e-05	0.000144	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.75e-05	0.000143	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	2.72e-05	0.000141	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.72e-05	0.000141	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.71e-05	0.000141	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.7e-05	0.00014	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	2.7e-05	0.00014	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	2.61e-05	0.000135	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	2.59e-05	0.000135	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	2.59e-05	0.000134	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.58e-05	0.000134	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	2.44e-05	0.000126	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.37e-05	0.000123	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.35e-05	0.000122	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	2.35e-05	0.000122	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TP53—amyotrophic lateral sclerosis	2.34e-05	0.000122	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.32e-05	0.00012	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.2e-05	0.000114	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	2.15e-05	0.000111	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.14e-05	0.000111	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	2.12e-05	0.00011	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.09e-05	0.000108	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.07e-05	0.000108	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TP53—amyotrophic lateral sclerosis	2.05e-05	0.000106	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	2.01e-05	0.000104	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.97e-05	0.000102	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.94e-05	0.000101	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.85e-05	9.59e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.83e-05	9.5e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.77e-05	9.19e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.72e-05	8.94e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.71e-05	8.85e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.71e-05	8.85e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.62e-05	8.41e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.58e-05	8.22e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	1.56e-05	8.07e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.41e-05	7.31e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.4e-05	7.28e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.4e-05	7.26e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.39e-05	7.23e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.34e-05	6.94e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.33e-05	6.89e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	1.3e-05	6.76e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.28e-05	6.65e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.15e-05	5.97e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.14e-05	5.92e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.08e-05	5.63e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	1.06e-05	5.5e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.06e-05	5.49e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	1.05e-05	5.47e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.05e-05	5.44e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.03e-05	5.32e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.2e-06	4.77e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	8.7e-06	4.52e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	8.63e-06	4.48e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.53e-06	3.9e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.22e-06	3.75e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.96e-06	3.61e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.92e-06	3.59e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.96e-06	3.09e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.91e-06	3.07e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	5.69e-06	2.95e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.9e-06	2.02e-05	CbGpPWpGaD
